PHILADELPHIA, July 24 /PRNewswire-FirstCall/ -- On Wednesday, July 26, 2006, GlaxoSmithKline plc will announce its second quarter financial results for the three months ended June 30, 2006. It is anticipated that the announcement will be released to the London Stock Exchange at approximately 7:00 AM U.S. Eastern Daylight Saving Time (DST).
Following the announcement, JP Garnier, Chief Executive Officer, David Stout, President, Pharmaceutical Operations and Julian Heslop, Chief Financial Officer, will hold a global teleconference where you will be able to listen to the presentation of the second quarter 2006 results.
This teleconference will take place on: Wednesday, July 26th at 9:00 AM Eastern To participate in the conference please dial one of the numbers below: UK Free Phone ......................0800 953 0905 U.S. Toll Free .....................1 866 213 5928 International Dial-in Number .......+44 (0) 1452 560 841 Please quote: GSK Q2 Results Meeting with Analysts and Investors
A recording of the teleconference will be available from 1:00 PM Eastern on July 26th (until August 2nd) on telephone numbers:
UK Free phone ......................0800 953 1533 U.S. Toll Free .....................1 866 247 4222 International Dial-in Number .......+44 (0) 1452 550 000 Passcode: ..........................7916261#
There will also be a live audio webcast of the results presentation with synchronized slides. It will begin at the same time as the teleconference, 9:00 AM Eastern, and can be accessed directly via the GlaxoSmithKline website: http://gsk.com. Slides will be available shortly before the teleconference on the GSK website.
An archived version of this webcast will be available from the corporate website at approximately 3:00 PM Eastern on the same day.
GlaxoSmithKline plc
CONTACT: U.S. Media inquiries: Nancy Pekarek, +1-215-751-7709; Mary AnneRhyne, +1-919-483-2839; Patty Seif, +1-215-751-7709; Gaile Renegar,+1-919-483-2839, all of GlaxoSmithKline plc
Web site: http://gsk.com/
Company News On-Call: http://www.prnewswire.com/comp/801350.html /
